Effect of Cyclandelate on Dementia | Zendy

Gilbert Westreich | Zendy; Milton Alter | Zendy; Sandra Lundgren | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Cyclandelate on Dementia

Author(s) -

Gilbert Westreich,

Milton Alter,

Sandra Lundgren

Publication year - 1975

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.6.5.535

Subject(s) - medicine , placebo , dementia , anesthesia , ischemia , cerebral arteriosclerosis , cardiology , disease , pathology , alternative medicine

Cyclandelate, a vasodilator, was administered to 24 patients with dementia. The dementia in these patients was presumed to be due to cerebral ischemia caused by atherosclerosis in cerebral vessels after other possible causes were ruled out. In a double-blind, cross-over study, patients received 200 mg of cyclandelate four times daily for six weeks and a placebo for six weeks. Six psychological tests, which reflect various aspects of higher cortical ability, were used to evaluate the effect of cyclandelate on the dementia. Cyclandelate was found to be no more effective than placebo in improving higher cortical function in these demented patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research